NCT02072746
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Cirrhosis, +10 more
- Locations
-
- University of Louisville Louisville, Kentucky, United States
Clinical trial condition
Substance-Related Disorders
Explore clinical trials studying Substance-Related Disorders. Study availability and eligibility vary by location and protocol.
4,201 public trials
565 recruiting studies
Substance-Related Disorders trial results
NCT02048852
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Nicotine Dependence, +2 more
- Locations
-
- UCONN Health Center Farmington, Connecticut, United States
- Hartford Hospital Hartford, Connecticut, United States
NCT02989493
- Conditions
- Alcohol-Related Disorders, Alcoholism, Anxiety Disorders, +7 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT02575183
- Conditions
- Behavior, Chemically-Induced Disorders, Health Behavior, +8 more
- Locations
-
- American University of Beirut Medical Center Beirut, Lebanon
- American University of Beirut Medical Center Beirut, Lebanon
NCT03361293
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Chemically-Induced Disorders, +7 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
NCT04043728
- Conditions
- Behavior, COPD, Chemically-Induced Disorders, +18 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
NCT00606801
- Conditions
- Chemically-Induced Disorders, Cocaine Abuse, Cocaine-Related Disorders, +2 more
- Locations
-
- Veterans Affairs Hospital West Haven, Connecticut, United States
Completed
Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)
NCT04033094
- Conditions
- Baseline Epidemiologic Assessment, Chemically-Induced Disorders, Drug Misuse, +4 more
- Locations
-
- Daiichi Sankyo, Inc. Basking Ridge, New Jersey, United States
NCT04203966
- Conditions
- Alcohol Use Disorder, Alcohol-Related Disorders, Alcoholism, +4 more
- Locations
-
- IoPPN, King's College London London, United Kingdom
NCT04708795
- Conditions
- Chemically-Induced Disorders, Marijuana Abuse, Mental Disorders, +4 more
- Locations
-
- Phase I Unit of CannaXan GmbH Warngau, Bavaria, Germany